BIOGEN INC. Quarterly Goodwill in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Biogen Inc. quarterly Goodwill history and growth rate from Q1 2010 to Q3 2024.
  • Biogen Inc. Goodwill for the quarter ending September 30, 2024 was $6.49B, a 4.73% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.49B -$322M -4.73% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $6.23B +$474M +8.23% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $6.23B +$476M +8.27% Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $6.22B +$470M +8.18% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $6.81B +$1.07B +18.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $5.75B +$4.1M +0.07% Jun 30, 2023 10-Q 2023-07-25
Q1 2023 $5.75B -$6.2M -0.11% Mar 31, 2023 10-Q 2023-04-25
Q4 2022 $5.75B -$12.1M -0.21% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $5.74B -$19.3M -0.34% Sep 30, 2022 10-Q 2022-10-25
Q2 2022 $5.75B -$14.3M -0.25% Jun 30, 2022 10-Q 2022-07-20
Q1 2022 $5.76B -$5.1M -0.09% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $5.76B -$1M -0.02% Dec 31, 2021 10-K 2024-02-14
Q3 2021 $5.76B +$4.8M +0.08% Sep 30, 2021 10-Q 2021-10-20
Q2 2021 $5.76B +$12.9M +0.22% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $5.76B +$11.1M +0.19% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 $5.76B +$4.3M +0.08% Dec 31, 2020 10-K 2023-02-15
Q3 2020 $5.76B +$9.6M +0.17% Sep 30, 2020 10-Q 2020-10-21
Q2 2020 $5.75B +$1.8M +0.03% Jun 30, 2020 10-Q 2020-07-22
Q1 2020 $5.75B +$112M +1.99% Mar 31, 2020 10-Q 2020-04-23
Q4 2019 $5.76B +$51.4M +0.9% Dec 31, 2019 10-K 2022-02-03
Q3 2019 $5.75B +$306M +5.63% Sep 30, 2019 10-Q 2019-10-22
Q2 2019 $5.75B +$579M +11.2% Jun 30, 2019 10-Q 2019-07-24
Q1 2019 $5.64B +$732M +14.9% Mar 31, 2019 10-Q 2019-04-24
Q4 2018 $5.71B +$1.07B +23.2% Dec 31, 2018 10-K 2021-02-03
Q3 2018 $5.44B +$1.31B +31.8% Sep 30, 2018 10-Q 2018-10-23
Q2 2018 $5.17B +$1.3B +33.6% Jun 30, 2018 10-Q 2018-07-24
Q1 2018 $4.91B +$1.3B +35.9% Mar 31, 2018 10-Q 2018-04-24
Q4 2017 $4.63B +$963M +26.3% Dec 31, 2017 10-K 2020-02-06
Q3 2017 $4.13B +$708M +20.7% Sep 30, 2017 10-Q 2017-10-24
Q2 2017 $3.87B +$703M +22.2% Jun 30, 2017 10-Q 2017-07-25
Q1 2017 $3.61B +$694M +23.8% Mar 31, 2017 10-Q 2017-04-25
Q4 2016 $3.67B +$1.01B +37.7% Dec 31, 2016 10-K 2019-02-06
Q3 2016 $3.42B +$1.01B +42% Sep 30, 2016 10-Q 2016-10-26
Q2 2016 $3.17B +$1.01B +47% Jun 30, 2016 10-Q 2016-07-21
Q1 2016 $2.92B +$1.07B +57.7% Mar 31, 2016 10-Q 2016-04-21
Q4 2015 $2.66B +$904M +51.3% Dec 31, 2015 10-K 2018-02-01
Q3 2015 $2.41B +$868M +56.3% Sep 30, 2015 10-Q 2015-10-21
Q2 2015 $2.15B +$790M +57.8% Jun 30, 2015 10-Q 2015-07-24
Q1 2015 $1.85B +$617M +50% Mar 31, 2015 10-Q 2015-04-24
Q4 2014 $1.76B +$527M +42.8% Dec 31, 2014 10-K 2017-02-02
Q3 2014 $1.54B +$330M +27.3% Sep 30, 2014 10-Q 2014-10-22
Q2 2014 $1.36B +$154M +12.7% Jun 30, 2014 10-Q 2014-07-23
Q1 2014 $1.23B +$22.2M +1.83% Mar 31, 2014 10-Q 2014-04-23
Q4 2013 $1.23B +$31.6M +2.63% Dec 31, 2013 10-K 2016-02-03
Q3 2013 $1.21B +$5.98M +0.5% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 $1.21B +$12.8M +1.07% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 $1.21B +$17.4M +1.46% Mar 31, 2013 10-Q 2013-04-25
Q4 2012 $1.2B +$55M +4.8% Dec 31, 2012 10-K 2015-02-04
Q3 2012 $1.2B +$58.4M +5.1% Sep 30, 2012 10-Q 2012-10-25
Q2 2012 $1.2B +$51.6M +4.5% Jun 30, 2012 10-Q 2012-07-24
Q1 2012 $1.19B +$47M +4.1% Mar 31, 2012 10-Q 2012-05-01
Q4 2011 $1.15B -$14K 0% Dec 31, 2011 10-K 2014-02-06
Q3 2011 $1.15B +$7.69M +0.68% Sep 30, 2011 10-Q 2011-10-28
Q2 2011 $1.15B +$7.69M +0.68% Jun 30, 2011 10-Q 2011-07-26
Q1 2011 $1.15B +$7.69M +0.68% Mar 31, 2011 10-Q 2011-04-21
Q4 2010 $1.15B Dec 31, 2010 10-K 2013-02-05
Q3 2010 $1.14B Sep 30, 2010 10-Q 2010-10-26
Q2 2010 $1.14B Jun 30, 2010 10-Q 2010-07-20
Q1 2010 $1.14B Mar 31, 2010 10-Q 2010-04-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.